Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane K Stock

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Atherosclerosis|March 25, 2021
Reply to: "It's time to stop the nonsense of withholding lipid lowering therapy on account of age" and "The evidence around safe and effective LDL cholesterol-lowering therapy in elderly individuals demands validity and clinical relevance"Jane K Stock
Atherosclerosis|October 23, 2021
Global Familial Hypercholesterolaemia Studies Collaboration (FHSC)Jane K Stock
Atherosclerosis|June 16, 2021
EAS Task Force gives practical guidance for combination lipid-modifying therapy in high- and very-high-risk patientsJane K Stock
Atherosclerosis|September 25, 2020
Residual inflammatory risk: Lessons from trials for the futureJane K Stock
Atherosclerosis|February 13, 2022
Novel insights into lipoprotein(a): News from AtherosclerosisJane K Stock
Atherosclerosis|September 15, 2020
HDL markers in cardiovascular risk prediction: Ethnicity mattersJane K Stock
Atherosclerosis|December 5, 2021
Joint statement from the European Atherosclerosis Society and European Society of Vascular Medicine focuses on patients with peripheral arterial diseaseJane K Stock
Atherosclerosis|March 5, 2022
Homozygous Familial Hypercholesterolaemia International Clinical Collaboration (HICC) registry: Levelling up access to treatment urgently neededJane K Stock
Atherosclerosis|August 28, 2021
Lipid Clinics Network targets suboptimal guideline implementationJane K Stock
Atherosclerosis|July 22, 2019
Highlights from the 87th EAS congress, 26-29th May 2019Jane K Stock
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Atherosclerosis|March 25, 2021
Reply to: "It's time to stop the nonsense of withholding lipid lowering therapy on account of age" and "The evidence around safe and effective LDL cholesterol-lowering therapy in elderly individuals demands validity and clinical relevance"Jane K Stock
Atherosclerosis|October 23, 2021
Global Familial Hypercholesterolaemia Studies Collaboration (FHSC)Jane K Stock
Atherosclerosis|June 16, 2021
EAS Task Force gives practical guidance for combination lipid-modifying therapy in high- and very-high-risk patientsJane K Stock
Atherosclerosis|September 25, 2020
Residual inflammatory risk: Lessons from trials for the futureJane K Stock
Atherosclerosis|February 13, 2022
Novel insights into lipoprotein(a): News from AtherosclerosisJane K Stock
Atherosclerosis|September 15, 2020
HDL markers in cardiovascular risk prediction: Ethnicity mattersJane K Stock
Atherosclerosis|December 5, 2021
Joint statement from the European Atherosclerosis Society and European Society of Vascular Medicine focuses on patients with peripheral arterial diseaseJane K Stock
Atherosclerosis|March 5, 2022
Homozygous Familial Hypercholesterolaemia International Clinical Collaboration (HICC) registry: Levelling up access to treatment urgently neededJane K Stock
Atherosclerosis|August 28, 2021
Lipid Clinics Network targets suboptimal guideline implementationJane K Stock
Atherosclerosis|July 22, 2019
Highlights from the 87th EAS congress, 26-29th May 2019Jane K Stock
Pageof 4